Abstract
After the occurrence of septicaemia with a vancomycin-resistant Enterococcus faecalis strain in a patient, it was decided to determine the number of carriers of vancomycin-resistant cocci among haematologic patients. During a period of six months 135 stool samples from 25 children, and 400 samples from 70 adults were studied. All samples from the children were negative for vancomycin-resistant cocci. Nine of the adult patients had cultures positive for cocci, all identified as enterococci, which were highly resistant to vancomycin (MIC greater than 250 micrograms/ml), sensitive to amoxicillin, moderately resistant to gentamicin, slightly resistant to teicoplanin, and sensitive to daptomycin. None of these patients had been given vancomycin prior to the isolation of the vancomycin-resistant enterococci.
MeSH Terms
Adult
Bone Marrow Transplantation
Child
Drug Resistance, Microbial
Humans
Leukemia/microbiology
Microbial Sensitivity Tests
Streptococcus/drug effects,isolation & purification
Vancomycin/pharmacology
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Guiot H F
Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.
Peetermans W E
Sebens F W
References (16)
16 references, click to expand
-
Increasing incidence of Gram-positive sepsis in cancer patients.
Med Pediatr Oncol. 1978;5(1):241-4
PMID: 745589
-
Alpha-hemolytic streptococci: clinical significance in the cancer patient.
Med Pediatr Oncol. 1978;4(4):367-70
PMID: 723799
-
Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria.
J Clin Microbiol. 1989 Apr;27(4):724-30
PMID: 2723037
-
Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.
Antimicrob Agents Chemother. 1989 Feb;33(2):198-203
PMID: 2497704
-
Comparison of physiologic tests used to identify non-beta-hemolytic aerococci, enterococci, and streptococci.
J Clin Microbiol. 1987 Oct;25(10):1845-50
PMID: 3117840
-
Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures.
Scand J Infect Dis. 1986;18(2):153-60
PMID: 3704563
-
Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
Neth J Med. 1987 Feb;30(1-2):64-74
PMID: 3473310
-
In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.
Antimicrob Agents Chemother. 1989 Aug;33(8):1383-4
PMID: 2552910
-
Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.
J Infect Dis. 1983 Apr;147(4):615-23
PMID: 6842002
-
Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.
Infection. 1989 Jul-Aug;17(4):240-4
PMID: 2767765
-
Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin.
Infection. 1990 May-Jun;18(3):131-7
PMID: 2365464
-
Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.
Antimicrob Agents Chemother. 1989 Jul;33(7):1121-4
PMID: 2528940
-
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.
Antimicrob Agents Chemother. 1989 Jan;33(1):10-5
PMID: 2523687
-
Microbiological properties of teicoplanin.
J Antimicrob Chemother. 1988 Jan;21 Suppl A:1-13
PMID: 2965119
-
High-level vancomycin-resistant enterococci causing hospital infections.
Epidemiol Infect. 1989 Aug;103(1):173-81
PMID: 2506070
-
Inducible, transferable resistance to vancomycin in Enterococcus faecium, D399.
J Antimicrob Chemother. 1989 Apr;23(4):503-8
PMID: 2501270